Granules India appoints Sucharita Rao Palepu as Non-executive Independent Director
Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services
Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
The drug has been granted permission by DCGI for emergency use as an adjunct therapy for Covid-19
Acetaminophen extended-release tablets 650 mg is bioequivalent of the reference listed drug Tylenol
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
ranules now has a total of 38 ANDA approvals from US FDA.
Granules now has a total of 37 ANDA approvals from US FDA (36 Final approvals and 1 tentative approvals).
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
New Board of Directors and management team at Suven Pharma also appointed
Subscribe To Our Newsletter & Stay Updated